A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Tuberculin Purified Protein Derivative (APLISOL)

Skin Test Antigen class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval1956-08-15
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$93.15/unit
2 NDCs benchmarked, lowest of all strengths.
Average NADAC
$106.76
Across all dosage forms in distribution.
Highest NADAC
$120.38
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Tuberculin Purified Protein Derivative used for?

Tuberculin Purified Protein Derivative is a Skin Test Antigen medication tracked in Medicare Part D.

Is there a generic for Tuberculin Purified Protein Derivative?

No. Tuberculin Purified Protein Derivative is brand-only with no generic equivalents currently in market.

How much does my plan pay for Tuberculin Purified Protein Derivative?

Across 329 Part D plans, Tuberculin Purified Protein Derivative averages $106.76/unit (NADAC). Lowest available: $93.15/unit. Highest in distribution: $120.38/unit.

Is Tuberculin Purified Protein Derivative on the FDA shortage list?

No. Tuberculin Purified Protein Derivative is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Skin Test Antigen1 alternative in D1
01
Coccidioides Immitis Spherule-Derived Skin Test Antigen
Brand: Spherusol
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.